Bridget E. Bunner

Array ( [id] => 6276454 [patent_doc_number] => 20100256231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'NOVEL DERIVATIVES OF 3,3-DIPHENYLPROPYLAMINES' [patent_app_type] => utility [patent_app_number] => 12/814982 [patent_app_country] => US [patent_app_date] => 2010-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 20359 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256231.pdf [firstpage_image] =>[orig_patent_app_number] => 12814982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8228708 [patent_doc_number] => 20120142911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'SYNTHESIS OF TTX INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 13/377787 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20677 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13377787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026405 [patent_doc_number] => 20110053994 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'POTENT IMMUNOSUPPRESSIVE AGENTS, DERIVATIVES AND USES' [patent_app_type] => utility [patent_app_number] => 12/813858 [patent_app_country] => US [patent_app_date] => 2010-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 18205 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053994.pdf [firstpage_image] =>[orig_patent_app_number] => 12813858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642707 [patent_doc_number] => 08367691 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Modulators of muscarinic receptors' [patent_app_type] => utility [patent_app_number] => 12/794202 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61481 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12794202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8496676 [patent_doc_number] => 20120296085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'CHEMILUMINESCENT DYES AND DYE-STAINED PARTICLES' [patent_app_type] => utility [patent_app_number] => 13/522296 [patent_app_country] => US [patent_app_date] => 2010-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7710 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6633673 [patent_doc_number] => 20100311946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Solid Phase Peptide for the Production of Goserelin' [patent_app_type] => utility [patent_app_number] => 12/787447 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13705 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311946.pdf [firstpage_image] =>[orig_patent_app_number] => 12787447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630451 [patent_doc_number] => 20100311720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Spiroindoline Modulators of Muscarinic Receptors' [patent_app_type] => utility [patent_app_number] => 12/785676 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35918 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311720.pdf [firstpage_image] =>[orig_patent_app_number] => 12785676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146893 [patent_doc_number] => 08163900 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Seven-membered heterocyclic carbenes and their metal complexes' [patent_app_type] => utility [patent_app_number] => 12/784537 [patent_app_country] => US [patent_app_date] => 2010-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9186 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163900.pdf [firstpage_image] =>[orig_patent_app_number] => 12784537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898135 [patent_doc_number] => 08921349 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Compounds and methods for treating AIDS and HIV infections' [patent_app_type] => utility [patent_app_number] => 13/319973 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 32971 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8103971 [patent_doc_number] => 08153625 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-10 [patent_title] => 'Nitrogen-containing heterocyclic compounds and medicinal use thereof' [patent_app_type] => utility [patent_app_number] => 12/776989 [patent_app_country] => US [patent_app_date] => 2010-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 117512 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/153/08153625.pdf [firstpage_image] =>[orig_patent_app_number] => 12776989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6551730 [patent_doc_number] => 20100222583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'DIAZAPHOSPHACYCLE TRANSITION METAL COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/774501 [patent_app_country] => US [patent_app_date] => 2010-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18081 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222583.pdf [firstpage_image] =>[orig_patent_app_number] => 12774501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8306066 [patent_doc_number] => 08227604 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity' [patent_app_type] => utility [patent_app_number] => 12/770079 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16949 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12770079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6576421 [patent_doc_number] => 20100273791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'TRICYCLIC PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/769861 [patent_app_country] => US [patent_app_date] => 2010-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8505 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273791.pdf [firstpage_image] =>[orig_patent_app_number] => 12769861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6571703 [patent_doc_number] => 20100234599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'METHOD FOR PREPARING ACID ADDITION SALTS OF POLYACIDIC BASIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/762111 [patent_app_country] => US [patent_app_date] => 2010-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11374 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234599.pdf [firstpage_image] =>[orig_patent_app_number] => 12762111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6518864 [patent_doc_number] => 20100216987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'SYNTHESIS OF NATURALLY OCCURING ECTEINASCIDINS AND RELATED COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/758182 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42734 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216987.pdf [firstpage_image] =>[orig_patent_app_number] => 12758182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778489 [patent_doc_number] => 20120040975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'BRIDGED BICYCLIC HETEROCYCLE DERIVATIVES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/260950 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28823 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040975.pdf [firstpage_image] =>[orig_patent_app_number] => 13260950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638046 [patent_doc_number] => 20100173913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'PYRIDO-AND PYRIMIDOPYRIMIDINE DERIVATIVES AS ANTI-PROLIFERATIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/724203 [patent_app_country] => US [patent_app_date] => 2010-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16939 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173913.pdf [firstpage_image] =>[orig_patent_app_number] => 12724203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6090381 [patent_doc_number] => 20110218153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'Topical Glutathione Formulations For Menopausal Skin' [patent_app_type] => utility [patent_app_number] => 12/718706 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3448 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20110218153.pdf [firstpage_image] =>[orig_patent_app_number] => 12718706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685270 [patent_doc_number] => 20130053554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'PREPARATION OF BLEACHING CATALYSTS' [patent_app_type] => utility [patent_app_number] => 13/582040 [patent_app_country] => US [patent_app_date] => 2010-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6885 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8208963 [patent_doc_number] => 20120128628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'COMBINATION OF A NUCLEOSIDE POLYMERASE INHIBITOR WITH A MACROCYCLIC PROTEASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF HEPATITIS C, LIVER FIBROSIS AND IMPAIRED LIVER FUNCTION (as amended)' [patent_app_type] => utility [patent_app_number] => 13/203334 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15300 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128628.pdf [firstpage_image] =>[orig_patent_app_number] => 13203334 [rel_patent_id] =>[rel_patent_doc_number] =>)